BISMUTH-BASED QUADRUPLE THERAPY (PYLERA) OVERCOMES H. PYLORI RESISTANCE IN THE EUROPEAN SETTING

(1) Axcan Pharma Inc, QC, Canada

(2) Med. Universität Magdeburg, Medizinische Fakultät, Gastroetnerol. und Hepatologie, Magdeburg, Germany



This item was part of the New insights in H. pylori infection session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A48

You may be interested in:

Vaccination
English, Presentation, European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), 2015

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2010